Multiallergen immunotherapy for allergic rhinitis and asthma.
about
Allergen-specific immunotherapy in pediatric allergic asthmaManagement of the polyallergic patient with allergy immunotherapy: a practice-based approachSubcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence?Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in ChildrenCurrent specific immunotherapy for allergic rhinitis: perspectives from otorhinolaryngologistsEpigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy.Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analysesThe efficacy assessment of a self-administered immunotherapy protocolImmunotherapy in asthma.One century of allergen-specific immunotherapy for respiratory allergy.One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions.The role of immunotherapy in the management of childhood asthma.Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications.Allergen extracts for immunotherapy: to mix or not to mix?A Survey of Korean Physicians' Prescription Patterns for Allergic Rhinitis.Multiallergen-specific immunotherapy in polysensitized patients: where are we?Quality of life improvement with sublingual immunotherapy: a prospective study of efficacy.Effect on quality of life of the mixed house dust mite/weed pollen extract immunotherapy.Trends in Specific Immunotherapy for Allergic Rhinitis: A Survey of Chinese ENT Specialists.EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.Subcutaneous versus sublingual immunotherapy.Forkhead box P3+ T cells express interleukin-17 in nasal mucosa of patients with both allergic rhinitis and polyposis.
P2860
Q26739254-8CC02B4B-1687-4C78-A6DA-43EC2AE2F402Q26772200-C616E243-7876-49BA-AA98-EC9377F61CB4Q26852119-5E37974E-5215-4293-8544-4AA27694DB56Q33586188-7DE73AB9-F525-43F2-B3F7-A74D18B2F6A4Q33831562-3D432707-B04A-4EDC-8EC7-B7787CA8F2BCQ34166561-2F1ACA03-3E0A-4196-9168-E8175AC9B1ADQ36411170-BFFE059B-7C7C-4CE4-B6D0-F7D25593CBB0Q36881918-B4B4E7E2-1B4E-4DE0-A76B-C08012A92EAEQ37793242-B501FD26-E0ED-47AA-9510-D4365B194BEEQ37873483-143A5FA8-B4FA-4551-93DD-D37C309DE59FQ37981739-EBEA7A78-A543-4271-A8C9-F1A885B60D5EQ37995986-5A97C0A6-CE0E-49C4-9FBB-A91F1DBB7F43Q38113269-7F0FF774-7B94-4732-9F6D-1EEB61EE2DE0Q38664847-DCB2B7DF-3909-4B66-BF7A-1E621FC08B98Q38816456-6F3F3CCE-B86B-4CF0-9AA9-4DF9E21BD0B1Q39466603-48C258C8-F4EF-48F9-AF74-E78CC9736F48Q42056231-7096BCED-C08C-48FD-A187-D84B2E9E6FF8Q42138073-5F7A3311-F632-4E3F-8BE9-6D1D8AC442F7Q42716940-D6DFF0CC-F694-4F47-9DCD-D78DDACFC792Q47764778-4F80252F-28A1-4253-8192-BC0DE645A74EQ48053554-5F772479-0E47-45FE-B76F-5F5A63B27B55Q48752584-557ED603-F291-4805-B8C6-663E48D05A02
P2860
Multiallergen immunotherapy for allergic rhinitis and asthma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multiallergen immunotherapy for allergic rhinitis and asthma.
@en
Multiallergen immunotherapy for allergic rhinitis and asthma.
@nl
type
label
Multiallergen immunotherapy for allergic rhinitis and asthma.
@en
Multiallergen immunotherapy for allergic rhinitis and asthma.
@nl
prefLabel
Multiallergen immunotherapy for allergic rhinitis and asthma.
@en
Multiallergen immunotherapy for allergic rhinitis and asthma.
@nl
P1476
Multiallergen immunotherapy for allergic rhinitis and asthma.
@en
P2093
Harold S Nelson
P304
P356
10.1016/J.JACI.2008.12.013
P407
P577
2009-02-13T00:00:00Z